Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2012, Article ID 310805, 4 pages
http://dx.doi.org/10.1155/2012/310805
Case Report

Rapid Multiorgan Dissemination of Low-Grade Myxofibrosarcoma: A Case Report

Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine, S-1, W-16, Chuo-ku, Sapporo, Hokkaido 060-8543, Japan

Received 1 May 2012; Revised 30 July 2012; Accepted 7 August 2012

Academic Editor: Robert Peter Gale

Copyright © 2012 Yasutaka Murahashi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. D. M. Fletcher, K. K. Unni, and F. Mertens, Eds., World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of Soft Tissue and Bone, IARC Press, Lyon, France, 2002.
  2. S. W. Weiss and F. M. Enzinger, “Myxoid variant of malignant fibrous histiocytoma,” Cancer, vol. 39, no. 4, pp. 1672–1685, 1977. View at Google Scholar · View at Scopus
  3. A. Elias, L. Ryan, A. Sulkes, J. Collins, J. Aisner, and K. H. Antman, “Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy,” Journal of Clinical Oncology, vol. 7, no. 9, pp. 1208–1216, 1989. View at Google Scholar · View at Scopus
  4. L. Angervall, L. G. Kindblom, and C. Merck, “Myxofibrosarcoma. A study of 30 cases,” Acta Pathologica et Microbiologica Scandinavica A, vol. 85, no. 2, pp. 127–140, 1977. View at Google Scholar · View at Scopus
  5. C. D. M. Fletcher, P. Gustafson, A. Rydholm, H. Willén, and M. Åkerman, “Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification,” Journal of Clinical Oncology, vol. 19, no. 12, pp. 3045–3050, 2001. View at Google Scholar · View at Scopus
  6. C. Merck, L. Angervall, L. Kindblom, and A. Oden, “Myxofibrosarcoma. A malignant soft tissue tumor of fibroblastic-histiocytic origin. A clinicopathologic and prognostic study of 110 cases using multivariate analysis,” Acta Pathologica Microbiologica et Immunologica Scandinavica, vol. 91, supplement 282, pp. 1–40, 1983. View at Google Scholar · View at Scopus
  7. A. Gronchi, S. Lo Vullo, C. Colombo et al., “Extremity soft tissue sarcoma in a series of patients treated at a single institution: local control directly impacts survival,” Annals of Surgery, vol. 251, no. 3, pp. 506–511, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Mentzel, E. Calonje, C. Wadden et al., “Myxofibrosarcoma: clinicopathologic analysis of 75 cases with emphasis on the low-grade variant,” American Journal of Surgical Pathology, vol. 20, no. 4, pp. 391–405, 1996. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Sanfilippo, R. Miceli, F. Grosso et al., “Myxofibrosarcoma: prognostic factors and survival in a series of patients treated at a single institution,” Annals of Surgical Oncology, vol. 18, no. 3, pp. 720–725, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Y. Huang, P. Lal, J. Qin, M. F. Brennan, and C. R. Antonescu, “Low-grade myxofibrosarcoma: a clinicopathologic analysis of 49 cases treated at a single institution with simultaneous assessment of the efficacy of 3-tier and 4-tier grading systems,” Human Pathology, vol. 35, no. 5, pp. 612–621, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Nakanishi, Y. Tomita, M. Ohsawa et al., “Tumor size as a prognostic indicator of histologic grade of soft tissue sarcoma,” Journal of Surgical Oncology, vol. 65, no. 3, pp. 183–187, 1997. View at Publisher · View at Google Scholar